Back to Trials
NCT06515184PHASE3Recruiting

Coenzyme Q10 for Gulf War Illness: A Replication Study

University of California, San Diego

Start Date

9/13/2024

Completion Date

12/1/2027

Summary

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Eligibility Criteria

Age Range: 50 years to No maximum

Inclusion Criteria: * Meets both CDC and Kansas deployment and symptom inclusion criteria. * Does not have a disqualifying condition. * Able to travel to a local Quest facility for study blood draws. * Adequate internet access to allow ZoomPro visit participation and remote survey completion. * Health prior to the Gulf War rated as "very good" or "excellent" (to exclude persons who may have had other health conditions with different mechanisms as the cause of their symptoms). * Willing to defer initiation of discretionary treatments or supplements during the expected course of study participation. Exclusion Criteria: * Participating in another clinical trial. * Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use. * On Coumadin/ warfarin. * Unable to participate for the required duration of the study.

Interventions

DRUG

PharmaNord Bio-Quinone Active CoQ10 Gold 100mg

DRUG

PharmaNord Placebo

DRUG

PharmaNord Bio-Quinone Active CoQ10 Gold 100mg

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Gulf War SyndromePersian Gulf SyndromeMitochondrial Disorder, Respiratory Chain

Locations

UC San Diego

La Jolla, California 92093

United States